Literature DB >> 16984250

The sodium-iodide symporter expression in placental tissue at different gestational age: an immunohistochemical study.

C Di Cosmo1, G Fanelli, M Tonacchera, E Ferrarini, A Dimida, P Agretti, G De Marco, P Vitti, A Pinchera, G Bevilacqua, A G Naccarato, P Viacava.   

Abstract

BACKGROUND: Iodide (I(-)) is crucial for foetal thyroid function. Foetal iodide results from maternal circulating iodide and from deiodination of iodothyronines within the placenta. The Na(+)/I(-) symporter (NIS) localized in placental cells appears to be involved in iodide exchange. Low NIS expression has been reported in trophoblast cells from the first trimester and pregnancy at term. AIMS: The aim of this study was to examine NIS expression by immunohistochemistry in the major components of human ovular tissue and placenta.
MATERIALS AND METHODS: Formalin-fixed and paraffin-embedded specimens of placental tissue from the first trimester and at term were analysed. NIS expression was quantified as percentage of NIS-positive cells/total cells. NIS expression was also evaluated by real-time polymerase chain reaction (RT-PCR) in five first-trimester and five at-term placental specimens.
RESULTS: In the first-trimester specimens heterogeneous NIS immunoreactivity was found in cyto-syncytiotrophoblast cells, with a range of NIS-positive cells from 5% to 80% (mean +/- SD 21.85 +/- 23.95), in mesenchymal and endothelial cells from 1% to 40% (14.5 +/- 11.16), in decidual cells from 5% to 40% (10.38 +/- 11.98) and in endometrial glands from 3% to 40% (21.86 +/- 13.93). In specimens from placenta at term, NIS-positive cyto-syncytiotrophoblast cells were between 5% and 40% (mean 17.85 +/- 18.15), mesenchymal and endothelial cells between 1% and 40% (13.67 +/- 12.16), decidual tissue between 5% and 30% (16.43 +/- 9.08), and endometrial glands between 3% and 40% (16.67 +/- 15.27). No significant differences in NIS expression were observed between the first trimester and placenta at term. A similar level of mRNA expression for the NIS gene was obtained by RT-PCR both in ovular material of the first trimester and in placenta at term.
CONCLUSIONS: We found NIS to be expressed in various placental and ovular components and its expression to remain constant during pregnancy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16984250     DOI: 10.1111/j.1365-2265.2006.02577.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  The Sodium/Iodide Symporter (NIS): Molecular Physiology and Preclinical and Clinical Applications.

Authors:  Silvia Ravera; Andrea Reyna-Neyra; Giuseppe Ferrandino; L Mario Amzel; Nancy Carrasco
Journal:  Annu Rev Physiol       Date:  2017-02-10       Impact factor: 19.318

2.  Regulation of iodide uptake in placental primary cultures.

Authors:  R Burns; C O'Herlihy; P P A Smyth
Journal:  Eur Thyroid J       Date:  2013-11-27

Review 3.  Relevance of solute carrier family 5 transporter defects to inherited and acquired human disease.

Authors:  Miryam Cannizzaro; Jana Jarošová; Boel De Paepe
Journal:  J Appl Genet       Date:  2019-07-08       Impact factor: 3.240

Review 4.  The Na+/I- symporter (NIS): mechanism and medical impact.

Authors:  Carla Portulano; Monika Paroder-Belenitsky; Nancy Carrasco
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

5.  False-positive uptake on radioiodine whole-body scintigraphy: physiologic and pathologic variants unrelated to thyroid cancer.

Authors:  Jong-Ryool Oh; Byeong-Cheol Ahn
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-07-10

6.  A Role for Iodide and Thyroglobulin in Modulating the Function of Human Immune Cells.

Authors:  Mahmood Y Bilal; Svetlana Dambaeva; Joanne Kwak-Kim; Alice Gilman-Sachs; Kenneth D Beaman
Journal:  Front Immunol       Date:  2017-11-15       Impact factor: 7.561

7.  Identification of placental nutrient transporters associated with intrauterine growth restriction and pre-eclampsia.

Authors:  Xiao Huang; Pascale Anderle; Lu Hostettler; Marc U Baumann; Daniel V Surbek; Edgar C Ontsouka; Christiane Albrecht
Journal:  BMC Genomics       Date:  2018-03-02       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.